Cargando…

A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021

Objective: Asthma drug research has been increasing yearly, and its clinical application value has increasingly attracted attention. This study aimed to analyze the development status, research hotspots, research frontiers, and future development trends of the research works on drugs for patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhen, Gao, Yingying, Liu, Weifang, Xu, Jingcheng, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574019/
https://www.ncbi.nlm.nih.gov/pubmed/36263119
http://dx.doi.org/10.3389/fphar.2022.916871
_version_ 1784811008752091136
author Zhen, Gao
Yingying, Liu
Weifang, Xu
Jingcheng, Dong
author_facet Zhen, Gao
Yingying, Liu
Weifang, Xu
Jingcheng, Dong
author_sort Zhen, Gao
collection PubMed
description Objective: Asthma drug research has been increasing yearly, and its clinical application value has increasingly attracted attention. This study aimed to analyze the development status, research hotspots, research frontiers, and future development trends of the research works on drugs for patients with asthma, especially severe asthma. Methods: Asthma drug-related articles published between 1982 and 2021 were retrieved from the Web of Science Core Collection (WOSCC) database, and only articles published in English were included. CiteSpace and VOSviewer software were utilized to conduct collaborative network analysis of countries/regions, institutions, keywords, and co-citation analysis of references. Results: A total of 3,234 asthma drug-related eligible articles were included. The United States was in a leading position, and Karolinska Institute (Sweden) was the most active institution. The most prolific journal in this field was Journal of Asthma, and the most cited journal was Journal of Allergy and Clinical Immunology. Keyword co-occurrence studies suggested that the current hotspots and frontiers were as follows: ① asthma: fully revealing the potential of existing conventional asthma drugs, determining the best drug delivery system, and indicating the best combination. To continue to explore potential targets for severe asthma or other phenotypes. Inhaled glucocorticoids and budesonide are still one of the important aspects of current asthma drug research and ② severe asthma: the research and development of new drugs, especially monoclonal antibodies including omalizumab, mepolizumab, and benralizumab to improve asthma control and drug safety, have become a research hotspot in recent years, highlighting the importance of “target” selection. Conclusion: This study demonstrates the global research hotspots and trends of the research works on drugs for patients with asthma/severe asthma. It can help scholars quickly understand the current status and hotspots of research in this field.
format Online
Article
Text
id pubmed-9574019
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95740192022-10-18 A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021 Zhen, Gao Yingying, Liu Weifang, Xu Jingcheng, Dong Front Pharmacol Pharmacology Objective: Asthma drug research has been increasing yearly, and its clinical application value has increasingly attracted attention. This study aimed to analyze the development status, research hotspots, research frontiers, and future development trends of the research works on drugs for patients with asthma, especially severe asthma. Methods: Asthma drug-related articles published between 1982 and 2021 were retrieved from the Web of Science Core Collection (WOSCC) database, and only articles published in English were included. CiteSpace and VOSviewer software were utilized to conduct collaborative network analysis of countries/regions, institutions, keywords, and co-citation analysis of references. Results: A total of 3,234 asthma drug-related eligible articles were included. The United States was in a leading position, and Karolinska Institute (Sweden) was the most active institution. The most prolific journal in this field was Journal of Asthma, and the most cited journal was Journal of Allergy and Clinical Immunology. Keyword co-occurrence studies suggested that the current hotspots and frontiers were as follows: ① asthma: fully revealing the potential of existing conventional asthma drugs, determining the best drug delivery system, and indicating the best combination. To continue to explore potential targets for severe asthma or other phenotypes. Inhaled glucocorticoids and budesonide are still one of the important aspects of current asthma drug research and ② severe asthma: the research and development of new drugs, especially monoclonal antibodies including omalizumab, mepolizumab, and benralizumab to improve asthma control and drug safety, have become a research hotspot in recent years, highlighting the importance of “target” selection. Conclusion: This study demonstrates the global research hotspots and trends of the research works on drugs for patients with asthma/severe asthma. It can help scholars quickly understand the current status and hotspots of research in this field. Frontiers Media S.A. 2022-10-03 /pmc/articles/PMC9574019/ /pubmed/36263119 http://dx.doi.org/10.3389/fphar.2022.916871 Text en Copyright © 2022 Zhen, Yingying, Weifang and Jingcheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zhen, Gao
Yingying, Liu
Weifang, Xu
Jingcheng, Dong
A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
title A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
title_full A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
title_fullStr A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
title_full_unstemmed A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
title_short A bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
title_sort bibliometric and scientific knowledge map study of the drug therapies for asthma-related study from 1982 to 2021
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574019/
https://www.ncbi.nlm.nih.gov/pubmed/36263119
http://dx.doi.org/10.3389/fphar.2022.916871
work_keys_str_mv AT zhengao abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021
AT yingyingliu abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021
AT weifangxu abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021
AT jingchengdong abibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021
AT zhengao bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021
AT yingyingliu bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021
AT weifangxu bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021
AT jingchengdong bibliometricandscientificknowledgemapstudyofthedrugtherapiesforasthmarelatedstudyfrom1982to2021